AbbVie’s Allergan reportedly files lawsuits over proposed generic ViberziMSN Labs and Sun Pharmaceutical are the only remaining defendants in a related consolidated case. Aurobindo receives FDA nod for generic ZoviraxAcyclovir oral suspension has a market value of roughly $10.4 million for the 12 months ending February 2022, according to IQVIA. Elite, Praxgen gain FDA OK for generic doxycycline Doxycycline Hyclate is an antibiotic that is used to treat a wide variety of bacterial infections. ANI welcomes new board member With Renee Tannenbaum's appointment, ANI’s board of directors totals nine members. Hikma debuts benztropine mesylate in vial format The medication is indicated as an adjunct in the therapy of all forms of Parkinsonism. Aurobindo receives FDA nod for 2 generics The company obtained approval for bromfenac ophthalmic solution and clobazam oral suspension. Mayne Pharma adds board member Custin, a U.S. resident, has almost 40 years of experience in the healthcare sector. Unichem obtains FDA OK for generic Bystolic Nebivolol tablets are indicated for the treatment of hypertension. Sandoz acquires Coalesce The acquisition of Coalesce is expected to help Sandoz build on its existing portfolio of respiratory medicines. Natco, Arrow International debut generic Revlimid Natco Pharma, along with its marketing partner Arrow International, recently launched the first generic of Revlimid in dosage strengths of 5 mg, 10 mg, 15 mg and 25 mg. First Previous 89 90 91 92 93 Next Last
